Investigators reported that 290 of 414 patients (70.05%; 95% CI: 65.64–74.46) had attained viral suppression by the end of follow-up (December 2022). The team calculated an incidence rate of 6.68 per 100 person-months (95% CI: 5.95–7.49). Median time to suppression in the cohort was 9.33 months (95% CI: 8.55–10.11). Short statement: suppression was substantially below the UNAIDS 95 goal.
These figures come from a public health setting in Shashemene City during the test-and-treat era. The sample comprised patients aged 15 years and older who initiated therapy between January 2018 and December 2021 and were followed for up to two years. The observed delay—median near nine months—signals that many patients did not reach undetectable viral load rapidly after initiation, despite the policy environment favoring earlier treatment.
The study team observed a clear association between timing of antiretroviral therapy and the hazard of achieving suppression. Rapid ART initiation was linked to about a twofold higher likelihood of earlier suppression (adjusted hazard ratio, aHR = 2.05; 95% CI: 1.58–2.67) relative to delayed initiation. The authors did not report the precise operational cut-off they used in the manuscript beyond describing rapid initiation within the test-and-treat time frame.
That association persisted in adjusted models, as reported by the investigators. They used survival analysis techniques to estimate time-to-event outcomes and to control for measured confounders available in the routine records. Rapid start policies therefore correlated with faster virologic response in this cohort, according to the data presented.
Baseline nutritional and functional measures influenced virologic outcomes. The cohort data indicated that undernourished patients had a lower hazard of early suppression (aHR = 0.54; 95% CI: 0.36–0.81) compared with well-nourished patients. The authors noted nutritional support as an actionable target to improve outcomes, but the paper did not describe any specific nutritional interventions delivered during follow-up.
Functional status at baseline exerted a strong effect. Patients recorded as ambulatory or bedridden had a markedly reduced chance of early suppression (aHR = 0.13; 95% CI: 0.07–0.27) compared with patients classified as working. That large effect size suggests coexisting illness or advanced disease may impede treatment response or adherence, although the study design does not allow causal attribution.
Adherence also predicted suppression. Patients with not-good adherence experienced a 36% reduction in the hazard of achieving suppression (aHR = 0.64; 95% CI: 0.41–0.99) relative to those with good adherence, as recorded in clinic files. The investigators identified adherence support as a priority in their recommendations.
This was a retrospective cohort study of 414 adolescents and adults (aged ≥15) who started ART between January 2018 and December 2021 and were followed through December 2022 in public health facilities in Shashemene City. Patients were selected by a proportional stratified random sampling technique from facility records. The study team used Kaplan-Meier methods to estimate median time to suppression and Cox proportional hazards regression to identify predictors.
The authors reported adjusted hazard ratios and 95% confidence intervals for associations between baseline factors and time to suppression. They provided data and supporting information within the paper. The manuscript did not specify certain implementation-level details—such as the proportion of same-day starts or the precise adherence measurement tool beyond routine clinic categorizations—so readers should interpret some operational conclusions with that limitation in mind.
Data indicated several program-relevant signals. Rapid initiation of ART correlated with earlier viral control in this cohort, supporting policies that reduce time from diagnosis to treatment start. Poor baseline nutritional status and impaired functional status identified subgroups at higher risk of delayed suppression; the authors recommend integrating nutritional support and intensified follow-up for those patients. Recorded poor adherence predicted lower suppression rates, pointing to the continued need for adherence counselling and retention strategies within test-and-treat platforms.
These implications derive from routine-care records and reflect outcomes in a city-level public health setting. The investigators emphasized strengthening rapid initiation, adherence support, and nutritional services to improve suppression rates in similar settings. The paper framed these as program priorities based on the observed adjusted associations.
The authors acknowledged, implicitly through study design and reporting, that this was an observational, retrospective analysis using routine data. That structure limits causal inference: associations between rapid initiation, nutrition, functional status, adherence and suppression cannot be assumed to be causal. The manuscript did not report certain operational details, such as the exact proportion who started same-day ART or the content and coverage of any nutritional or adherence interventions, and those absences constrain implementation translation.
Remaining questions include whether targeted nutritional interventions or intensified clinical support for ambulatory/bedridden patients would change time to suppression, and how same-day initiation proportions and post-initiation retention dynamics influenced longer-term viral outcomes. The authors made clear recommendations for program strengthening but left these specific effectiveness questions open for prospective evaluation.